These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14993096)

  • 21. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
    Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
    Béïque JC; Lavoie N; de Montigny C; Debonnel G
    Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
    Lu NZ; Eshleman AJ; Janowsky A; Bethea CL
    Mol Psychiatry; 2003 Mar; 8(3):353-60. PubMed ID: 12660809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).
    Ansah TA; Ramamoorthy S; Montañez S; Daws LC; Blakely RD
    J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.
    Samuvel DJ; Jayanthi LD; Bhat NR; Ramamoorthy S
    J Neurosci; 2005 Jan; 25(1):29-41. PubMed ID: 15634764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
    Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
    J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer.
    Hummerich R; Reischl G; Ehrlichmann W; Machulla HJ; Heinz A; Schloss P
    J Neurochem; 2004 Sep; 90(5):1218-26. PubMed ID: 15312176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.
    Hoepping A; Johnson KM; George C; Flippen-Anderson J; Kozikowski AP
    J Med Chem; 2000 May; 43(10):2064-71. PubMed ID: 10821718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
    Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
    J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130.
    Taber MT; Wright RN; Molski TF; Clarke WJ; Brassil PJ; Denhart DJ; Mattson RJ; Lodge NJ
    Pharmacol Biochem Behav; 2005 Mar; 80(3):521-8. PubMed ID: 15740795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological properties of new 2beta-alkyl- and 2beta-aryl-3-(substituted phenyl)tropane derivatives: stereochemical effect of C-3 on affinity and selectivity for neuronal dopamine and serotonin transporters.
    Kozikowski AP; Araldi GL; Prakash KR; Zhang M; Johnson KM
    J Med Chem; 1998 Dec; 41(25):4973-82. PubMed ID: 9836615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.
    Zhu CB; Carneiro AM; Dostmann WR; Hewlett WA; Blakely RD
    J Biol Chem; 2005 Apr; 280(16):15649-58. PubMed ID: 15728187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. A species-scanning mutagenesis study.
    Larsen MB; Elfving B; Wiborg O
    J Biol Chem; 2004 Oct; 279(40):42147-56. PubMed ID: 15271993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
    Sur C; Betz H; Schloss P
    J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.